Login

Switch On Your HIV Smarts.

New European Guidelines Recommend ART for All, PrEP for Those at Risk

New European Guidelines Recommend ART for All, PrEP for Those at Risk

, by Liz Highleyman

European AIDS Clinical Society treatment guidelines align with U.S. recommendations on universal HIV treatment but extend PrEP to non-daily dosing. Read More

Study: Protease Inhibitor Monotherapy Does Not Limit Future Treatment Options

Study: Protease Inhibitor Monotherapy Does Not Limit Future Treatment Options

, by Emily Newman

Will it ever make sense for people with suppressed viral loads to switch from combination therapy to a type of monotherapy? Read More

Is Dolutegravir Alone Enough to Control HIV?

Is Dolutegravir Alone Enough to Control HIV?

, by Liz Highleyman

Results of studies presented at the European AIDS Conference could lead to simpler, better tolerated, and easier to take regimens for people with difficult-to-treat HIV. Read More

A Close-Up on Facial Fillers

A Close-Up on Facial Fillers

, by Emily Newman

Mark S. King describes his decision to undergo procedures to reverse the effects of facial lipoatrophy on TheBody.com. Read More

Genvoya: A New Once-Daily Combo HIV Medication

Genvoya: A New Once-Daily Combo HIV Medication

, by Emily Newman

People taking Stribild will soon have another option with reduced risk of side effects. Read More